Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
about
Locoregional treatment of early breast cancer with isolated tumor cells or micrometastases on sentinel lymph node biopsyImaging methods for the local lymphatic system of the axilla in early breast cancer in patients qualified for sentinel lymph node biopsyPostmastectomy radiation therapy after neoadjuvant chemotherapy: review and interpretation of available dataSentinel Lymph Node in Breast Cancer: Review Article from a Pathologist's Point of ViewAmerican Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care GuidelineLandmark trials affecting the surgical management of invasive breast cancerThe evolution of the locoregional therapy of breast cancerMapping lymph nodes in cancer management - role of (99m)Tc-tilmanocept injectionSentinel lymph node biopsy in bladder cancer: Systematic review and technology updateDual-Modality Photoacoustic and Ultrasound Imaging System for Noninvasive Sentinel Lymph Node Detection in Patients with Breast Cancer.X-ray-induced shortwave infrared biomedical imaging using rare-earth nanoprobes.Use of indocyanine green for detecting the sentinel lymph node in breast cancer patients: from preclinical evaluation to clinical validationOptimal management of breast cancer in the elderly patient: current perspectivesManagement of Axilla in 2015 in Indian ScenarioAxillary treatment for operable primary breast cancer.A brief account of nanoparticle contrast agents for photoacoustic imaging.A Green Synthesis of Carbon Nanoparticle from Honey for Real-Time Photoacoustic ImagingAxillary lymph node dissection for breast cancer utilizing Harmonic FocusĀ®Is primary surgery of breast cancer patients consistent with German guidelines? Twelve-year trend of population-based clinical cancer registry data.Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis.The Noninvasive Treatment for Sentinel Lymph Node Metastasis by Photodynamic Therapy Using Phospholipid Polymer as a Nanotransporter of VerteporfinShould we examine sentinel lymph nodes during the operation?Sentinel lymph node biopsy in esophageal cancer: an essential step towards individualized careIntraoperative Injection of Technetium-99m Sulfur Colloid for Sentinel Lymph Node Biopsy in Breast Cancer Patients: A Single Institution Experience.Local treatment of the axilla in early breast cancer: concepts from the national surgical adjuvant breast and bowel project B-04 to the planned intergroup sentinel mamma trialSurvival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trialFeasibility of preoperative (125)I seed-guided tumoural tracer injection using freehand SPECT for sentinel lymph node mapping in non-palpable breast cancer.Management of the Positive Axilla in 2017Outcome of Breast Cancer Patients Treated outside of Clinical TrialsThe impact of covariate misclassification using generalized linear regression under covariate-adaptive randomization.What to Do with Non-visualized Sentinel Nodes? A Dutch Nationwide Survey Study.Ablative techniques for the treatment of benign and malignant breast tumours.Axillary lymph node dissection on the run?Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures.Does our better understanding of breast cancer also improve the way we treat it?Advances in managing breast cancer: a clinical updateRelationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32.Differential gene expression in primary breast tumors associated with lymph node metastasis.Effect of occult metastases on survival in node-negative breast cancer.St. Gallen 2011: Summary of the Consensus Discussion.
P2860
Q26747688-F56C88F4-70BC-42E0-A7D6-3BE7E74A7881Q26751906-DBA36F12-96CD-42CE-BBF4-C72863F7E1CFQ26769835-1527F2F0-7300-4600-BEA6-979CB0E0C195Q26772240-7E75D8F5-9938-4B19-8CA6-451D9CD63AC7Q26773986-CF2CFC56-437F-4D56-BBD2-4E6C8366A235Q26830129-2F0F8053-5B04-4ECE-A68F-1E555D678A9EQ26992321-F2012A6A-4061-46BA-8AAF-EC46990D26C0Q27022042-40FC5FD9-740D-48D0-A2E5-4EA9740ADEF6Q27027693-7CB1CFE7-99BA-4617-B3EE-40AC76502A30Q27308066-897DDD16-AA56-4270-A2E1-7948397BCA51Q27335168-68E76439-D00C-4BC9-8CEE-D3D4F3A76B90Q27336227-5F9756CC-14EB-405D-8234-BA203E534C9FQ27690879-18104354-61F5-405B-9159-F004275675FFQ28079495-86D327FD-6F4A-470F-B14B-0661F1A96535Q30239832-A92A7A00-0ED9-4F63-9C29-64A8A273FE1AQ30427324-EF627CF6-6950-4F3D-8D55-AEAFA1F5FDCFQ30453076-13BE002D-192D-45DB-9C22-2895CED57980Q30474173-8E4BDE8E-48D8-4881-8E84-4859FF93BF31Q30789643-33293D41-32B7-4E15-82DA-7817A8C8149FQ31022615-2A3C072B-35C6-4DD4-8D22-498522BB6197Q33572096-E0F788E6-4119-41E9-B74D-F989DD576816Q33601658-7356AA16-D56D-4DEB-B186-0745527F7159Q33606088-A7FADA29-F7E0-4634-919D-22B91022204AQ33608067-0DE9E13B-BC14-473F-B133-36BE0EC9FF8EQ33684856-75312D4F-DBA1-4994-8C4E-E55FBEC94363Q33733790-E8865E58-5D9E-4E7F-B072-9679E766669FQ33738451-F05F5B67-503B-45A0-8D20-155A56D63F64Q33752466-054E914F-286E-4171-871B-5AAE69BD5A1EQ33789421-38ABBF48-AC3E-4394-8C4D-E05960A3F3DFQ33812362-DE41FB81-BF6A-4AA4-9D77-C9BEF211616BQ33854781-9EAEA0D1-5106-4330-A0A8-A86DD3EC73FFQ33864124-F06D687B-6A4F-446F-9203-10244960436EQ33896875-5E3F2F58-E1DE-4D11-AB32-1435E70F475EQ33939588-E72AA432-E36F-4A18-8F4F-DB289400B576Q33972970-B567F281-9D9A-4EA5-B625-D9B02997D0A9Q34019904-B331241F-492B-448D-AB09-DA1FC0A184B8Q34039923-9C21B31E-101E-41E5-AAD1-B08E28F5245CQ34147751-0A24DF54-0B89-4EFC-930D-AE190F47D5A7Q34159750-E209947A-4985-4772-A7FA-D92B2F54B65DQ34189116-2A3EED9E-752A-427C-8CF7-B4C5C0D5A66B
P2860
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
description
2010 nĆ® lÅ«n-bĆ»n
@nan
2010 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« ÕÕøÕÆÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2010 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ°ÕøÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2010幓ć®č«ę
@ja
2010幓č«ę
@yue
2010幓č«ę
@zh-hant
2010幓č«ę
@zh-hk
2010幓č«ę
@zh-mo
2010幓č«ę
@zh-tw
2010幓č®ŗę
@wuu
name
Sentinel-lymph-node resection ...... B-32 randomised phase 3 trial
@ast
Sentinel-lymph-node resection ...... B-32 randomised phase 3 trial
@en
Sentinel-lymph-node resection ...... B-32 randomised phase 3 trial
@nl
type
label
Sentinel-lymph-node resection ...... B-32 randomised phase 3 trial
@ast
Sentinel-lymph-node resection ...... B-32 randomised phase 3 trial
@en
Sentinel-lymph-node resection ...... B-32 randomised phase 3 trial
@nl
prefLabel
Sentinel-lymph-node resection ...... B-32 randomised phase 3 trial
@ast
Sentinel-lymph-node resection ...... B-32 randomised phase 3 trial
@en
Sentinel-lymph-node resection ...... B-32 randomised phase 3 trial
@nl
P2093
P2860
P921
P1433
P1476
Sentinel-lymph-node resection ...... B-32 randomised phase 3 trial
@en
P2093
AndrƩ Robidoux
Ann M Brown
David N Krag
Donald L Weaver
Eleftherios P Mamounas
Hugh Mc Scarth
Joseph P Costantino
Lynne M Jalovec
Norman Wolmark
R Dirk Noyes
P2860
P304
P356
10.1016/S1470-2045(10)70207-2
P577
2010-10-01T00:00:00Z